Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

被引:52
|
作者
Beaton, Melanie D. [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Gastroenterol, London, ON, Canada
关键词
Fibrosis; Hepatic steatosis; Metabolic syndrome; Treatment; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; VITAMIN-E; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BARIATRIC SURGERY; IRON DEPLETION; METFORMIN;
D O I
10.1155/2012/725468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MD Beaton. current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. can J gastroenterol 2012;26(6):353-358. Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 50 条
  • [21] Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
    Kim, Soo Ki
    Kim, Ke Ih
    Kim, Soo Ryang
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1147 - 1153
  • [22] Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis
    Qamar, Amir A.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 : S28 - S32
  • [23] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Masayoshi Kage
    Shinichi Aishima
    Hironori Kusano
    Hirohisa Yano
    [J]. Journal of Medical Ultrasonics, 2020, 47 : 549 - 554
  • [24] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
    Younossi, Zobair M.
    [J]. LIVER TRANSPLANTATION, 2018, 24 (02) : 166 - 170
  • [25] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Yurie Soejima
    Toshio Fukusato
    [J]. World Journal of Gastroenterology, 2012, (19) : 2300 - 2308
  • [26] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kazankov, Konstantin
    Jorgensen, Simon Mark Dahl
    Thomsen, Karen Louise
    Moller, Holger Jon
    Vilstrup, Hendrik
    George, Jacob
    Schuppan, Detlef
    Gronbaek, Henning
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 145 - 159
  • [27] The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Konstantin Kazankov
    Simon Mark Dahl Jørgensen
    Karen Louise Thomsen
    Holger Jon Møller
    Hendrik Vilstrup
    Jacob George
    Detlef Schuppan
    Henning Grønbæk
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 145 - 159
  • [28] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Soejima, Yurie
    Fukusato, Toshio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (19) : 2300 - 2308
  • [29] Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Gawrieh, Samer
    Chalasani, Naga
    [J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 189 - +
  • [30] Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Sakamoto, Michiie
    Tsujikawa, Hanako
    Effendi, Kathryn
    Ojima, Hidenori
    Harada, Kenichi
    Zen, Yoh
    Kondo, Fukuo
    Nakano, Masayuki
    Kage, Masayoshi
    Sumida, Yoshio
    Hashimoto, Etsuko
    Yamada, Gotaro
    Okanoue, Takeshi
    Koike, Kazuhiko
    [J]. PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 1 - 7